In the news this week: the CQC publishes its 2019 ‘State of Care’ report, the government proposes a new patient safety regulator, an inexpensive drug could ‘save thousands of lives a year’ from head injuries, and could British HIV-positive patients living in Spain lose their healthcare post-Brexit?
When German physicist, Wilhelm Conrad Röntgen, discovered the technique of producing x-rays it wasn’t actually what he was trying to do. It was an accident, so it got us thinking about other accidental discoveries in medicine.
An innovation that combines data analytics and wearable technology to prevent falls is shortlisted in an awards category, the Axis-D pen-injector tech is to be licensed for development in diabetes treatment, and Northern Ireland’s Stormont is given £31m to prepare for a no-deal Brexit.
The value of pharma ‘ecosystems’ is discussed, the Pf Power List 2019 is revealed, the NAO says there will be delays in medicine supplies in a no-deal Brexit, and how can China’s pharma market offer opportunities for UK drug manufacturers?
Nursing and healthcare news this week: UK government reveals ‘no deal’ protection for UK nationals in the EU, new plans are unveiled to strengthen nursing leadership in PCNs, Bayer’s Vitrakvi is cleared for cancer treatment, and ‘half as many’ Brits vape as smoke.
Laser marking technology is “essential” to tracking reusable medical devices, engineers have developed a way to detect physiological signals coming from the skin, a robotic surgical developer raises £195m in funding, and a CE-marked app detects 95% of skin cancer.
Novo Nordisk is to launch a cut-price version of its insulin drug, a Slovakian biotech sees positive developments in its Alzheimer’s drug, the NHS looks at making statins available for pharmacists, and AZ’s cancer drug Imfinzi shows significant survival benefits.
The BMA warns a no-deal Brexit could worsen a winter healthcare crisis, NICE recommends a novel gene therapy for a rare inherited eye disorder, NHS nurses are to be given funding to help develop their careers, and NHS Digital pushes the pros of digital tools.
A review documents the rise of wearable medical devices, the Neurorehabilitation devices market is expected to expand with the prevalence of disorders, an accelerator backs two innovations with £150k, and the devices packaging industry is set to grow by $12.7 billion.
PM Boris Johnson orders action to crack down on measles, a leaked document forecasts no-deal Brexit shortages, both AbbVie and Celgene receive approval from the FDA, and experts in digital health warn that AI may not be able to keep up with ‘real-world’ medical use.